A Phase III, Randomized, Open Label Trial of Nivolumab in combination with Ipilimumab versus Pemetrexed with Cisplatin or Carboplatin as First Line Therapy in unresectable Pleural Mesothelioma

  • Alamgeer, Muhammad (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date12/02/19 → 11/02/24